| BIICX | MNMWX | BIICX / MNMWX | |
| Total Expense Ratio | 0.57 | 0.10 | 570% |
| Annual Report Gross Expense Ratio | 0.68 | 0.77 | 88% |
| Fund Existence | 18 years | 7 years | - |
| Gain YTD | 4.391 | 2.823 | 156% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 10.5B | 260M | 4,038% |
| Annual Yield % from dividends | 5.95 | 3.64 | 164% |
| Returns for 1 year | 9.29 | 3.92 | 237% |
| Returns for 3 years | 30.98 | 19.23 | 161% |
| Returns for 5 years | 22.23 | 6.15 | 361% |
| Returns for 10 years | 68.03 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BITI | 25.96 | 0.67 | +2.65% |
| ProShares Shrt Bitcoin ETF | |||
| EAGG | 46.81 | -0.17 | -0.36% |
| iShares ESG U.S. Aggregate Bond ETF | |||
| AVSU | 87.69 | -0.75 | -0.85% |
| Avantis Responsible US Equity ETF | |||
| THNR | 25.64 | -0.29 | -1.11% |
| Amplify Weight Loss Drug & Treatment ETF | |||
| EMOP | 49.52 | -1.64 | -3.20% |
| AB Emerging Markets Opportunities ETF | |||